Our Purpose
The Clinical Proteomics Platform aims to exploit the latest technological developments in mass spectrometry and immunoassay for the discovery, validation and use of biomarkers in various human pathologies (proteins, RNA, DNA, metabolites).
Our Approach
Several technological approaches oriented towards the use of clinical samples and high throughput are available, including mass spectrometry (MRM and HRMS) and ultra-sensitive immunoassays (SIMOA and MSD).
Our Mission
Integrated in the Montpellier Proteome Cluster since its creation and IBiSA labeled, its mission is equally to make medical, biological and technical expertise in Clinical Proteomics available to academic and industrial teams. The PPC has been ISO 9001 certified since 2014.
Latest news :
Kōichi Tanaka, Docteur Honoris Causa
La Faculté d’Odontologie de Montpellier a eu l’honneur d’accueillir Kōichi Tanaka, Prix Nobel de Chimie 2002, à l’occasion de sa nomination au titre de Docteur Honoris Causa de l’Université de Montpellier. Cette distinction, portée par le parrainage du Pr...
CSF Society 2026
This year, the 5th meeting of the society for CSF analysis and clinical neurochemistry was held in Montpellier on the 4th and 5th of June 2026. This conferernce brings together students, PhD candidates, postdoctoral researchers, senior scientists, and clinicians...
A special visit
We were pleased to welcome Mr. Lionel DA CRUZ and his team from the Ministry of Health’s Office of Research and Innovation to the PPC at the Research and Innovation Center of the Montpellier University Hospital. We discussed innovation in healthcare and the role of...
The PPC in a nutshell :
Employees
Years of experience
Ongoing projects
Patents
Clinical Proteomics Platform
Institute for Regenerative Medicine & Biotherapy (IRMB)
Hôpital Saint Eloi
80 rue Augustin Fliche
34295 MONTPELLIER – Cedex 5
FRANCE